ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GYRE Gyre Therapeutics Inc

10.62
0.00 (0.00%)
Pre Market
Last Updated: 04:00:15
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 794k000000113.45M
Operating Income -14.7M-5.72M-5.17M-40.22M-4.56M-2.54M-2.82M-53.97M
Pre Tax Income -14.54M51.63M-4.88M-40.11M274k-2.47M-1.58M-73.19M
Net Income -14.54M51.63M-4.88M-40.45M260k-2.47M-1.58M-89.15M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -14.72M51.53M-5.17M-40.27M178k-2.54M-1.62M-64.76M
EBITDA -14.59M-5.65M-5.13M-40.21M-4.56M-2.54M-2.82M-52.9M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 399k1.02M6k020.95M7.34M794k113.45M
Operating Income -20.42M-21.82M-33.82M-57.28M-57.37M-87.89M-65.8M-63.89M
Pre Tax Income -16.95M-21.56M-30.06M-55.18M-56.24M-87.93M-7.89M-76.97M
Net Income -16.95M-25.51M-30.06M-55.18M-56.24M-87.93M-8.24M-92.93M
Preferred Dividends 0-3.95M000000
Basic Earnings Per Share (EPS) -21.128-4.195-2.514-4.583-2.545-2.8-0.218-2.447
EBIT -18.1M-21.56M-32.29M-57.32M-56.8M-87.97M-8.61M-68.75M
EBITDA -20.03M-21.65M-33.67M-57.13M-57.23M-87.6M-65.57M-62.82M